Skip to main content
Log in

Current IQWiG* guidelines do not provide an “appropriate foundation for informing German decision makers about the value of a health technology,”

  • Comment
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Dong H.Methods of economic evaluation for the German statutory healthcare system. PharmacoEconomics 27: 1-4, No. 1, Jan 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Current IQWiG* guidelines do not provide an “appropriate foundation for informing German decision makers about the value of a health technology,”. Pharmacoecon. Outcomes News 573, 3 (2009). https://doi.org/10.2165/00151234-200905730-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905730-00004

Keywords

Navigation